These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26407183)

  • 1. Emperipolesis in a patient receiving romiplostim.
    Cooper N; Bain BJ
    Am J Hematol; 2016 Jan; 91(1):166. PubMed ID: 26407183
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of romiplostim in patients with eltrombopag-resistant or -intolerant immune thrombocytopenia.
    Tsukamoto S; Nakaseko C; Takeuchi M; Kumagai K; Komatsu T; Tanaka H; Hara S; Koizumi M; Imai H; Yokota A; Takeuchi M; Inokuchi K; Matsuura Y; Aotsuka N; Wakita H
    Br J Haematol; 2013 Oct; 163(2):286-9. PubMed ID: 23862773
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia.
    Tarantino MD; Bussel JB; Blanchette VS; Beam D; Roy J; Despotovic J; Raj A; Carpenter N; Mehta B; Eisen M
    Haematologica; 2019 Nov; 104(11):2283-2291. PubMed ID: 30846500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Romplostim in the treatment of immune thrombocytopenic purpura at a tertiary hospital].
    Riu Viladoms G; Creus Baró N; Estefanell Tejero A; Ribas Sala J
    Farm Hosp; 2012; 36(5):434-7. PubMed ID: 22871365
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of Immune Thrombocytopenic Purpura (ITP) with the thrombopoietin-mimetic romiplostim.
    Meletis J; Katsandris A; Raptis SD; Mantzourani M
    Med Sci Monit; 2010 Aug; 16(8):CS100-2. PubMed ID: 20671616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Romiplostim: new drug. Thrombocytopenic purpura: for selected patients, with close monitoring.
    Prescrire Int; 2009 Dec; 18(104):246. PubMed ID: 20020571
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined romiplostim and intravenous immunoglobulin therapy increased platelet count, facilitating splenectomy in a patient with refractory immune thrombocytopenic purpura unresponsive to monotherapy.
    Mitsuhashi K; Ishiyama M; Imai Y; Shiseki M; Mori N; Teramura M; Seshimo A; Motoji T
    Br J Haematol; 2012 Sep; 158(6):798-800. PubMed ID: 22758388
    [No Abstract]   [Full Text] [Related]  

  • 8. Relative potency of the thrombopoietin receptor agonists eltrombopag, avatrombopag and romiplostim in a patient with chronic immune thrombocytopenia.
    Al-Samkari H; Kuter DJ
    Br J Haematol; 2018 Oct; 183(2):168. PubMed ID: 29978577
    [No Abstract]   [Full Text] [Related]  

  • 9. Romiplostim or standard of care in patients with immune thrombocytopenia.
    Kuter DJ; Rummel M; Boccia R; Macik BG; Pabinger I; Selleslag D; Rodeghiero F; Chong BH; Wang X; Berger DP
    N Engl J Med; 2010 Nov; 363(20):1889-99. PubMed ID: 21067381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly fluctuating thrombocytopenia developing in a patient with immune thrombocytopenia (ITP) while administering romiplostim.
    Shinohara K; Kambara N
    Intern Med; 2012; 51(11):1399-401. PubMed ID: 22687850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP).
    Shirasugi Y; Ando K; Miyazaki K; Tomiyama Y; Iwato K; Okamoto S; Kurokawa M; Kirito K; Hashino S; Ninomiya H; Mori S; Yonemura Y; Usuki K; Wei H; Lizambri R
    Int J Hematol; 2012 Jun; 95(6):652-9. PubMed ID: 22532046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Romiplostim for Treatment of Primary Immune Thrombocytopenia From a Pharmacokinetic and Pharmacodynamic Perspective.
    Yang BB; Doshi S; Arkam K; Franklin J; Chow AT
    Clin Pharmacokinet; 2016 Sep; 55(9):1045-58. PubMed ID: 27056734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of rituximab and a thrombopoietin receptor agonist in high-risk refractory immune thrombocytopenic purpura.
    Veneri D; Soligo L; Pizzolo G; Ambrosetti A
    Blood Transfus; 2015 Oct; 13(4):694-5. PubMed ID: 26057496
    [No Abstract]   [Full Text] [Related]  

  • 14. Pseudothrombocytopenia in a patient receiving romiplostim for immune thrombocytopenic purpura.
    Fozza C; Pardini S; Marras T; Longu F; Isoni A; Contini S; Longinotti M
    Ann Hematol; 2014 May; 93(5):899-900. PubMed ID: 24081576
    [No Abstract]   [Full Text] [Related]  

  • 15. A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice.
    Steurer M; Quittet P; Papadaki HA; Selleslag D; Viallard JF; Kaiafa G; Janssens A; Kozak T; Wadenvik H; Schoonen M; Belton L; Kreuzbauer G
    Eur J Haematol; 2017 Feb; 98(2):112-120. PubMed ID: 27557853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Romiplostim in chronic immune thrombocytopenic purpura.
    Cersosimo RJ
    Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Romiplostim: an advance in the treatment of idiopathic thrombocytopenic purpura].
    Mingot Castellano ME
    Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():39-43. PubMed ID: 21381287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological and clinical profile of romiplostim (Romiplate(®) 250 µg for s.c. injection)].
    Furuya Y; Ishii H; Aono Y; Arai Y; Onda F; Hasegawa K; Yanagida M
    Nihon Yakurigaku Zasshi; 2011 Jul; 138(1):34-9. PubMed ID: 21747207
    [No Abstract]   [Full Text] [Related]  

  • 19. Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial.
    Shirasugi Y; Ando K; Miyazaki K; Tomiyama Y; Okamoto S; Kurokawa M; Kirito K; Yonemura Y; Mori S; Usuki K; Iwato K; Hashino S; Wei H; Lizambri R
    Int J Hematol; 2011 Jul; 94(1):71-80. PubMed ID: 21706145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep vein thrombosis associated with a single dose of romiplostim in a high-risk patient.
    Przespo E; Elefante A
    Am J Health Syst Pharm; 2012 Jan; 69(2):131-3. PubMed ID: 22215358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.